Publications and communications of Francois PAQUOT

PAQUOT, F., & Jouret, F. (September 2023). Vignette diagnostique de l’étudiant. Approche diagnostique de la rhabdomyolyse. Revue Médicale de Liège, 78 (9), 529 - 532.

PAQUOT, F., WEEKERS, L., BONVOISIN, C., Pottel, H., & Jouret, F. (01 July 2019). "Acute kidney dysfunction with no rejection" is associated with poor renal outcomes at 2 years post kidney transplantation. BMC Nephrology, 20 (1), 249. doi:10.1186/s12882-019-1444-5

BOUQUEGNEAU, A., Evenepoel, P., PAQUOT, F., MALAISE, O., CAVALIER, E., & DELANAYE, P. (2019). Sclerostin within the chronic kidney disease spectrum. Clinica Chimica Acta, 502, 84-90. doi:10.1016/j.cca.2019.12.008

DELANAYE, P., PAQUOT, F., BOUQUEGNEAU, A., Blocki, F., Krzesinski, J.-M., Evenepoel, P., Pottel, H., & Cavalier, E. (2018). Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know. Nephrology Dialysis Transplantation, 33 (8), 1404-1410. doi:10.1093/ndt/gfx282

PAQUOT, F., DELANAYE, P., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Maillard, N., Pottel, H., Evenepoel, P., & CAVALIER, E. (2018). Variations of sclerostin with other bone biomarkers over a one-year period in hemodialysis patients [letter to the editor]. Clinica Chimica Acta, 486, 183-184. doi:10.1016/j.cca.2018.08.003

PAQUOT, F., & Krzesinski, J.-M. (2017). Inhibiteurs de la pompe à protons et risque d'insuffisance rénale. Revue Médicale Suisse.

Paquot, F., HUART, J., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (2017). Implications of the calcium-sensing receptor in ischemia/reperfusion. Acta Cardiologica, 72 (2), 125-131. doi:10.1080/00015385.2017.1291136

PAQUOT, F., Pottel, H., BONVOISIN, C., WEEKERS, L., & JOURET, F. (2017). "Acute kidney dysfunction with no rejection (ADNR)" is associated with poor outcomes in kidney transplant recipients. Transplant International, 30 ((Suppl. 2)), 558.

PAQUOT, F., BOUQUEGNEAU, A., CAVALIER, E., & DELANAYE, P. (2016). Sclérostine & insuffisance rénale: que nous apprennent les différents méthodes de dosage? Néphrologie et Thérapeutique, 12 (5), 374.

Dachy, A., Paquot, F., Debray, F.-G., Bovy, C., Christensen, E. I., Collard, L., & Jouret, F. (2015). In-depth phenotyping of a Donnai-Barrow patient helps clarify proximal tubule dysfunction. Pediatric Nephrology, 30 (6), 1027-31. doi:10.1007/s00467-014-3037-7